Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

[Level of interferon-gamma, tumor necrosis factor alpha, and antibodies to them in blood serum from Parkinson disease patients].

Gribova IE, Gnedenko BB, Poleshchuk VV, Morozov SG.

Biomed Khim. 2003 Mar-Apr;49(2):208-12. Russian.

PMID:
14565085
2.

[Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].

Wang W, Zhang MH, Yu Y, Xu CG.

Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):681-4. Chinese.

PMID:
18399174
3.

Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.

Robak E, Sysa-Jedrzejewska A, Dziankowska B, Torzecka D, Chojnowski K, Robak T.

Arch Immunol Ther Exp (Warsz). 1998;46(6):375-80.

PMID:
9883317
4.

Significant alterations of serum cytokine levels in patients with Peyronie's disease.

Zimmermann RP, Feil G, Bock C, Hoeltl L, Stenzl A.

Int Braz J Urol. 2008 Jul-Aug;34(4):457-66; discussion 466.

5.

Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma.

Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Kulig A, Malecka-Panas E.

Neoplasma. 2009;56(1):56-62.

PMID:
19152246
7.

Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.

Arora V, Verma J, Marwah V, Kumar A, Anand D, Das N.

Lupus. 2012 May;21(6):596-603. doi: 10.1177/0961203311434937. Epub 2012 Feb 2.

PMID:
22300832
8.

[Association between cytokines and trichloroethylene-induced hypersensitivity dermatitis].

Zang D, Yi J, Dong HY, Zhou W, Huang XQ, Duan HW, Bin P, Niu Y, Zheng YX, Dai YF.

Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Sep;46(9):836-9. Chinese.

PMID:
23157890
9.

FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debré P, Agid Y, Dugas B, Hirsch EC.

J Neurosci. 1999 May 1;19(9):3440-7.

10.
11.

Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?

Gómez D, Correa PA, Gómez LM, Cadena J, Molina JF, Anaya JM.

Semin Arthritis Rheum. 2004 Jun;33(6):404-13.

PMID:
15190525
12.

Tear levels of tumor necrosis factor-alpha in patients with Parkinson's disease.

Çomoğlu SS, Güven H, Acar M, Öztürk G, Koçer B.

Neurosci Lett. 2013 Oct 11;553:63-7. doi: 10.1016/j.neulet.2013.08.019. Epub 2013 Aug 20.

PMID:
23973333
14.

Inflammatory cytokines and NT-proCNP in Parkinson's disease patients.

Koziorowski D, Tomasiuk R, Szlufik S, Friedman A.

Cytokine. 2012 Dec;60(3):762-6. doi: 10.1016/j.cyto.2012.07.030. Epub 2012 Aug 19.

PMID:
22910321
15.

Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.

Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S.

Lupus. 2012 Sep;21(10):1105-12. doi: 10.1177/0961203312451200. Epub 2012 Jun 29.

PMID:
22759859
16.
19.

Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease.

Scalzo P, Kümmer A, Cardoso F, Teixeira AL.

J Neuroimmunol. 2009 Nov 30;216(1-2):122-5. doi: 10.1016/j.jneuroim.2009.08.001. Epub 2009 Sep 3.

PMID:
19732964
20.

Comparison of serum and cell-specific cytokines in humans.

Jason J, Archibald LK, Nwanyanwu OC, Byrd MG, Kazembe PN, Dobbie H, Jarvis WR.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1097-103.

Supplemental Content

Support Center